Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy in Combination With 10% ALA Gel Red Light PDT in the Treatment of Actinic Keratosis on the Full Face
NCT06745999Phase 4Active, not recruiting
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- May 2023
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aminolevulinic acid 10% gel in actinic keratosis (AK) (2 arms), sponsored by Psoriasis Treatment Center of Central New Jersey. Primary endpoint: Percentage change in total lesions at 24 weeks. Started May 2023; status: active, not recruiting.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06745999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745999.